ACTA1 and hepatocellular carcinoma: Immunohistochemical (IHC) staining analysis of hepatocellular carcinoma (HCC) patients shows a significantly shorter disease-free survival rate in patients with tumors overexpressing α-SMA [15, 16], and the same negative correlation was shown in colorectal cancer (CRC) and breast cancer [17, 18].